John Paulson reinforces his bullish views on Enzymotec Ltd (NASDAQ:ENZY). A recent 13G filing shows that his fund, Paulson & Co, more than doubled its passive stake in the company from 1.7 million shares to about 4.2 million. The new stake represents nearly 20% ownership of Enzymotec and is worth approximately $112 million.
Jacob Gottlieb‘s Visium Asset Management is another hedge fund that has recently raised its interest in Enzymotec Ltd (NASDAQ:ENZY). The fund increased its stake in the company from the previously held 690 thousand shares to 1.14 million, which represent 5.2% of Enzymotec’s common stock and are worth approximately $31 million. Other funds holding stock of Enzymotec Ltd (NASDAQ:ENZY) include Richard Driehaus‘ Driehaus Capital with 83.9 thousand shares worth $2.27 million and Gavin Saitowitz‘ Springbok Capital with 10 thousand shares worth $0.27 million.
Enzymotec Ltd (NASDAQ:ENZY) is a leading global supplier of specialty lipid-based products and solutions. Since its initial public offering held at a price of $14 per share in September 2013, the company nearly doubled its share price, selling 5.4 million shares at $28 per share in its first seasoned equity offering closed on the 5th of March, 2014. In 2013 Enzymotec generated revenues of $64.98 million, nearly double the result of $37.87 million for 2012, and currently trades at a P/E ratio of roughly 26 versus the industry average of 37.6. Analysts estimate an increase in earnings per share to $0.86 for 2014 from the $0.48 observed in 2013 and, on average, recommend that investors buy the stock.
Services, Technology, and Basic Materials represent approximately 2/3 of Paulson & Co’s equity portfolio value, with the largest stake (7.2% worth $1.46 billion) invested in 55.7 million shares of Extended Stay America Inc (NYSE:STAY). Other significant investments include 35.2 million shares of Vodafone Group Plc (ADR) (NASDAQ:VOD) and about 6 million shares of Time Warner Cable Inc (NYSE:TWC), with an aggregate value of the holdings of $2.19 billion. Recently, it has been revealed that the hedge fund seeks to acquire two beachfront hotels in Puerto Rico.